Page last updated: 2024-08-05 13:33:32

aminopiperidine

null

ChEBI ID: 48588

Members (3)

MemberDefinitionRole
AZD3463A member of the class of indoles that is 1H-indole substituted by a 2-[4-(4-aminopiperidin-1-yl)-2-methoxyanilino]-5-chloropyrimidin-4-yl group at position 3. It is an orally bioavailable dual inhibitor of ALK and IGF1R with Ki value of 0.75 nM for ALK.AZD3463
crenolanibA member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a 8-(4-aminopiperidin-1-yl)quinolin-2-yl group at position 1 and by a (3-methyloxetan-3-yl)methoxy group at position 5. It is an inhibitor of type III tyrosine kinases, PDGFRalpha/beta and FLT3 (IC50 of 11, 3.2, and 4 nM). Currently under clinical development for the treatment of acute myeloid leukemia.crenolanib
linagliptinA xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes.linagliptin

Research

Studies (643)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (2.18)29.6817
2010's440 (68.43)24.3611
2020's189 (29.39)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials153 (22.70%)5.53%
Reviews103 (15.28%)6.00%
Case Studies25 (3.71%)4.05%
Observational13 (1.93%)0.25%
Other380 (56.38%)84.16%